Related Experiment Video
Updated: Jun 11, 2025
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
5.8K
Amelanotic Melanoma: A Rare Sinonasal Malignancy
K V Apoorva1, Simran Bhatia1, S Vijendra Shenoy1
1Department of ENT and Head & Neck Surgery, Kasturba Medical College, Mangalore Manipal Academy of Higher Education, Manipal, India.
Summary
This case study highlights a rare amelanotic sinonasal melanoma diagnosis. Early detection and multidisciplinary care are crucial for managing aggressive sinonasal malignancies.
Area of Science:
- Oncology
- Pathology
- Otorhinolaryngology
Background:
- Mucosal melanomas are rare, aggressive sinonasal malignancies (<1% of all sinonasal cancers).
- Nonspecific symptoms often delay diagnosis, complicating treatment and management.
- Amelanotic variants present diagnostic challenges due to lack of pigmentation.
Purpose of the Study:
- To present a case of amelanotic sinonasal melanoma in a 75-year-old female.
- To emphasize diagnostic challenges and the importance of a comprehensive diagnostic approach.
- To highlight the role of immunohistochemistry in differential diagnosis.
Main Methods:
- Clinical presentation of epistaxis and nasal blockage.
- Diagnostic workup including imaging and histopathology.
- Immunohistochemistry to confirm amelanotic melanoma and exclude other sinonasal tumors.
- Surgical excision followed by adjuvant chemotherapy and radiotherapy.
Main Results:
- Definitive diagnosis of amelanotic sinonasal melanoma achieved despite bleeding during biopsy.
- Immunohistochemistry successfully differentiated melanoma from olfactory neuroblastoma and lymphoma.
- Successful surgical resection followed by adjuvant therapy for advanced-stage disease.
Conclusions:
- Amelanotic sinonasal melanoma requires a high index of suspicion and thorough diagnostic evaluation.
- Multidisciplinary team approach and immunohistochemistry are vital for accurate diagnosis.
- Personalized treatment strategies, considering molecular characteristics, are essential for improving outcomes in rare sinonasal malignancies.
